Back to NVCT
BlackRock, Inc. NVCT Position History
Nuvectis Pharma, Inc. • Healthcare
Quarters held
23
Latest value
$494K
Q3 2026
Peak value
$18.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $37K |
| Q4 2025 | $296K |
| Q4 2025 | $198K |
| Q4 2025 | $4.1M |
| Q4 2025 | $1.3M |
| Q4 2025 | $7K |
| Q1 2026 | $36K |
| Q1 2026 | $306K |
| Q1 2026 | $203K |
| Q1 2026 | $4M |
| Q1 2026 | $1.3M |
| Q2 2026 | $110K |
| Q2 2026 | $921K |
| Q2 2026 | $706K |
| Q2 2026 | $12.1M |
| Q2 2026 | $4.6M |
| Q2 2026 | $809 |
| Q3 2026 | $176K |
| Q3 2026 | $1.2M |
| Q3 2026 | $1M |
| Q3 2026 | $18.1M |
| Q3 2026 | $6.7M |
| Q3 2026 | $494K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $494K | 23.4K | — | — |
| Q3 2026 | $6.7M | 317.8K | — | — |
| Q3 2026 | $18.1M | 855.1K | — | — |
| Q3 2026 | $1M | 47.4K | — | — |
| Q3 2026 | $1.2M | 54.9K | — | — |
| Q3 2026 | $176K | 8.3K | — | — |
| Q2 2026 | $809 | 44 | — | — |
| Q2 2026 | $4.6M | 249.5K | — | — |
| Q2 2026 | $12.1M | 657.3K | — | — |
| Q2 2026 | $706K | 38.4K | — | — |
| Q2 2026 | $921K | 50.1K | — | — |
| Q2 2026 | $110K | 6.0K | — | — |
| Q1 2026 | $1.3M | 174.4K | — | — |
| Q1 2026 | $4M | 519.5K | — | — |
| Q1 2026 | $203K | 26.2K | — | — |
| Q1 2026 | $306K | 39.6K | — | — |
| Q1 2026 | $36K | 4.7K | — | — |
| Q4 2025 | $7K | 914 | — | — |
| Q4 2025 | $1.3M | 173.6K | — | — |
| Q4 2025 | $4.1M | 537.9K | — | — |
| Q4 2025 | $198K | 26.2K | — | — |
| Q4 2025 | $296K | 39.2K | — | — |
| Q4 2025 | $37K | 4.9K | — | — |